VEA vs VTHRX: 20% overlap
Vanguard FTSE Developed Markets ETF and Vanguard Target Retirement 2030 share 19.6% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 3 months apart — VTHRX as of 2026-03-31, the rest through 2026-06-30. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.8. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
VEA and VTHRX hold 3,792 of the same securities. The ten contributing most to the overlap figure:
| Holding | in VEA | in VTHRX | Δ |
|---|---|---|---|
| CASH | 1.4% | 1.9% | 0.5% |
| 005930 | 3.1% | 0.6% | 2.6% |
| 000660 | 3.0% | 0.5% | 2.5% |
| ASML | 2.3% | 0.4% | 1.9% |
| HSBA | 1.0% | 0.2% | 0.8% |
| ROP | 0.9% | 0.2% | 0.7% |
| RY | 0.9% | 0.2% | 0.7% |
| SAN | 0.9% | 0.2% | 0.7% |
| NOVN | 0.9% | 0.2% | 0.7% |
| AZN | 0.9% | 0.2% | 0.7% |
Where VEA and VTHRX differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | VEA | VTHRX | Δ |
|---|---|---|---|
| Treasuries | 0.0% | 13.6% | −13.6pp |
| Industrials | 16.9% | 6.9% | +9.9pp |
| Financials | 20.7% | 11.3% | +9.4pp |
| MBS Pass-Through | 0.0% | 5.7% | −5.7pp |
| Unclassified | 8.9% | 13.3% | −4.4pp |
| Corporate — industrial & other | 0.0% | 4.4% | −4.4pp |
| Materials | 5.1% | 2.0% | +3.1pp |
| Consumer Staples | 5.6% | 2.7% | +2.9pp |
Δ is VEA minus VTHRX, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
0.0% of VEA by weight, held in no part of VTHRX.
78.6% of VTHRX by weight, held in no part of VEA.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| VEA | VTHRX | |
|---|---|---|
| Top 10 holdings | 15.2% | 28.9% |
| Positions held | 3,792 | 7 |
| Cost per $10,000 held, per year | $3 | $8 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do VEA and VTHRX overlap?
VEA and VTHRX overlap 19.6% by portfolio weight — moderate overlap. They share 3,792 holdings. The figure comes from current issuer holdings files (VEA as of 2026-06-30, VTHRX as of 2026-03-31).
How is the overlap between VEA and VTHRX calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If VEA holds a stock at 6% and VTHRX holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both VEA and VTHRX?
That depends on your goals — we state facts, not advice. At 19.6% overlap, each fund still contributes meaningfully distinct exposure.
What does VEA own that VTHRX doesn't?
VEA holds 3,792 positions and VTHRX holds 7; 0 of VEA's positions don't appear in VTHRX at all, and they are 0.0% of VEA by weight.
You probably hold more than two funds
This page compares VEA and VTHRX. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch VEA vs VTHRX
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, VEA as of 2026-06-30, VTHRX as of 2026-03-31. Weights are fractions of each fund. Diagnostics, not advice.